Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.72 EUR | -0.86% | +4.46% | -11.60% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Evolution of the average Target Price on Formycon AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- FYB Stock
- FYB Stock
- Consensus Formycon AG